Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Podocyte-Specific Deletion of Myh9 Encoding Nonmuscle Myosin Heavy Chain 2A Predisposes Mice to Glomerulopathy

Podocyte-Specific Deletion of Myh9 Encoding Nonmuscle Myosin Heavy Chain 2A Predisposes Mice to... Podocyte-Specific Deletion of Myh9 Encoding Nonmuscle Myosin Heavy Chain 2A Predisposes Mice to Glomerulopathy ▿ Duncan B. Johnstone 1 , Jidong Zhang 1 , Britta George 1 , Catherine Léon 2 , Christian Gachet 2 , Hetty Wong 1 , Rulan Parekh 3 and Lawrence B. Holzman 1 , * 1 Renal, Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, 380 South University Ave., Philadelphia, Pennsylvania 19104-4539 2 UMR_S949 INSERM-Université de Strasbourg, Etablissement Français du Sang-Alsace, Strasbourg, France 3 Hospital for Sick Children, Toronto, Ontario, Canada ABSTRACT Genome-wide association studies linked single-nucleotide polymorphisms (SNPs) at the MYH9 locus to chronic kidney disease among African-Americans, particularly glomerular diseases such as HIV nephropathy and idiopathic focal and segmental glomerulosclerosis (FSGS). However, these MYH9 SNPs are intronic, and despite extensive sequencing, a causal variant remains elusive. To investigate the role of MYH9 in kidney disease, we selectively deleted Myh9 from mouse podocytes and found that mutant C57BL/6 mice did not develop renal insufficiency or proteinuria compared to control littermates, even when the mice were aged for 9 months. To explain the surprisingly normal phenotype, we considered genetic redundancy with the paralog Myh10 in podocytes, but we found that Myh10 was not expressed in podocytes in Myh9 -deficient or control mice. We tested whether Myh9 podocyte deletion predisposed mice to glomerulopathy in response to injury by doxorubicin hydrochloride (Adriamycin), and we found that Myh9 podocyte-deleted mice developed proteinuria and glomerulosclerosis, while control mice were resistant. In summary, Myh9 podocyte deletion in C57BL/6 mice results in susceptibility to experimental doxorubicin hydrochloride glomerulopathy. We review evidence that MYH9 dysfunction in humans results in similar susceptibility and place our data, the first examination of Myh9 kidney disease in experimental animals, in the context of recent findings in human kidney disease, including the role of APOL1 . http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Molecular and Cellular Biology American Society For Microbiology

Podocyte-Specific Deletion of Myh9 Encoding Nonmuscle Myosin Heavy Chain 2A Predisposes Mice to Glomerulopathy

Podocyte-Specific Deletion of Myh9 Encoding Nonmuscle Myosin Heavy Chain 2A Predisposes Mice to Glomerulopathy

Molecular and Cellular Biology , Volume 31 (10): 2162 – May 15, 2011

Abstract

Podocyte-Specific Deletion of Myh9 Encoding Nonmuscle Myosin Heavy Chain 2A Predisposes Mice to Glomerulopathy ▿ Duncan B. Johnstone 1 , Jidong Zhang 1 , Britta George 1 , Catherine Léon 2 , Christian Gachet 2 , Hetty Wong 1 , Rulan Parekh 3 and Lawrence B. Holzman 1 , * 1 Renal, Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, 380 South University Ave., Philadelphia, Pennsylvania 19104-4539 2 UMR_S949 INSERM-Université de Strasbourg, Etablissement Français du Sang-Alsace, Strasbourg, France 3 Hospital for Sick Children, Toronto, Ontario, Canada ABSTRACT Genome-wide association studies linked single-nucleotide polymorphisms (SNPs) at the MYH9 locus to chronic kidney disease among African-Americans, particularly glomerular diseases such as HIV nephropathy and idiopathic focal and segmental glomerulosclerosis (FSGS). However, these MYH9 SNPs are intronic, and despite extensive sequencing, a causal variant remains elusive. To investigate the role of MYH9 in kidney disease, we selectively deleted Myh9 from mouse podocytes and found that mutant C57BL/6 mice did not develop renal insufficiency or proteinuria compared to control littermates, even when the mice were aged for 9 months. To explain the surprisingly normal phenotype, we considered genetic redundancy with the paralog Myh10 in podocytes, but we found that Myh10 was not expressed in podocytes in Myh9 -deficient or control mice. We tested whether Myh9 podocyte deletion predisposed mice to glomerulopathy in response to injury by doxorubicin hydrochloride (Adriamycin), and we found that Myh9 podocyte-deleted mice developed proteinuria and glomerulosclerosis, while control mice were resistant. In summary, Myh9 podocyte deletion in C57BL/6 mice results in susceptibility to experimental doxorubicin hydrochloride glomerulopathy. We review evidence that MYH9 dysfunction in humans results in similar susceptibility and place our data, the first examination of Myh9 kidney disease in experimental animals, in the context of recent findings in human kidney disease, including the role of APOL1 .

Loading next page...
 
/lp/american-society-for-microbiology/podocyte-specific-deletion-of-myh9-encoding-nonmuscle-myosin-heavy-gFlmG0aH9I

References (34)

Publisher
American Society For Microbiology
Copyright
Copyright © 2011 by the American society for Microbiology.
ISSN
0270-7306
eISSN
1098-5549
DOI
10.1128/MCB.05234-11
pmid
21402784
Publisher site
See Article on Publisher Site

Abstract

Podocyte-Specific Deletion of Myh9 Encoding Nonmuscle Myosin Heavy Chain 2A Predisposes Mice to Glomerulopathy ▿ Duncan B. Johnstone 1 , Jidong Zhang 1 , Britta George 1 , Catherine Léon 2 , Christian Gachet 2 , Hetty Wong 1 , Rulan Parekh 3 and Lawrence B. Holzman 1 , * 1 Renal, Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, 380 South University Ave., Philadelphia, Pennsylvania 19104-4539 2 UMR_S949 INSERM-Université de Strasbourg, Etablissement Français du Sang-Alsace, Strasbourg, France 3 Hospital for Sick Children, Toronto, Ontario, Canada ABSTRACT Genome-wide association studies linked single-nucleotide polymorphisms (SNPs) at the MYH9 locus to chronic kidney disease among African-Americans, particularly glomerular diseases such as HIV nephropathy and idiopathic focal and segmental glomerulosclerosis (FSGS). However, these MYH9 SNPs are intronic, and despite extensive sequencing, a causal variant remains elusive. To investigate the role of MYH9 in kidney disease, we selectively deleted Myh9 from mouse podocytes and found that mutant C57BL/6 mice did not develop renal insufficiency or proteinuria compared to control littermates, even when the mice were aged for 9 months. To explain the surprisingly normal phenotype, we considered genetic redundancy with the paralog Myh10 in podocytes, but we found that Myh10 was not expressed in podocytes in Myh9 -deficient or control mice. We tested whether Myh9 podocyte deletion predisposed mice to glomerulopathy in response to injury by doxorubicin hydrochloride (Adriamycin), and we found that Myh9 podocyte-deleted mice developed proteinuria and glomerulosclerosis, while control mice were resistant. In summary, Myh9 podocyte deletion in C57BL/6 mice results in susceptibility to experimental doxorubicin hydrochloride glomerulopathy. We review evidence that MYH9 dysfunction in humans results in similar susceptibility and place our data, the first examination of Myh9 kidney disease in experimental animals, in the context of recent findings in human kidney disease, including the role of APOL1 .

Journal

Molecular and Cellular BiologyAmerican Society For Microbiology

Published: May 15, 2011

There are no references for this article.